Last $74.91 USD
Change Today +2.33 / 3.21%
Volume 907.9K
MDVN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Stuttgart
As of 8:10 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

C. Patrick MacHado

AgeTotal Calculated CompensationThis person is connected to 28 board members in 2 different organizations across 2 different industries.

See Board Relationships
49$1,082,490
As of Fiscal Year 2013

Background*

Mr. C. Patrick Machado, also known as Pat, is a Co-Founder of Medivation, Inc. Mr. Machado served as the Chief Financial Officer, Principal Accounting Officer and Chief Business Officer at Medivation, Inc., until April 18, 2014. He served as an Interim Chief Business and Financial Officer at Medivation, Inc., since November 2013. He served as Chief Financial Officer and Senior Vice President of Orion Acquisition Corp. II since December 17, 2004 and also served as its ...

Read Full Background

Corporate Headquarters*

525 Market Street
San Francisco, California 94105

United States

Phone: 415-543-3470
Fax: 415-543-3411

Board Members Memberships*

2014-Present
Director and Member of Audit Committee
2014-Present
Director

Education*

BA
Santa Clara University
BS
Santa Clara University
JD
Harvard Law School

Other Affiliations*

Annual Compensation*

Salary$480,400
Total Annual Compensation$480,400

Stock Options*

All Other Compensation$11,190
Exercisable Options572,105
Exercisable Options Value$28,579,170
Unexercisable Options114,453
Unexercisable Options Value$3,925,230
Total Value of Options$32,504,400
Total Number of Options686,558

Total Compensation*

Total Annual Cash Compensation$1,082,490
Total Short Term Compensation$480,400
Other Long Term Compensation$11,190
Total Calculated Compensation$1,082,490
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDVN:US $74.91 USD +2.33

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Clay B. Siegall Ph.D.Co-Founder, Chairman, Chief Executive Officer and President
Seattle Genetics Inc.
$724.4K
John H. Johnson Chief Executive Officer and President
Dendreon Corp.
$800.0K
Daniel G. Welch Chairman, Chief Executive Officer and President
InterMune, Inc.
$703.4K
Shailesh Ayyangar B.V.Fc & A.H., P.G.D.M.Managing Director, Vice President of South Asia - Global Operations, Executive Director and Member of Audit Committee
Sanofi India Limited
8.6M
Michael L. Babich Chief Executive Officer, President and Director
INSYS Therapeutics, Inc.
$1.0M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDIVATION INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.